Patents by Inventor Clare Lees

Clare Lees has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240170105
    Abstract: An intermediate data set can be generated based on an image of a set of objects, where each of the set of objects includes a plastic. A predicted chemometric property can be generated by inputting the intermediate data set to a machine-learning model. The chemometric property can be of a physical output pyrolysis oil produced by performing a pyrolysis processing of the set of objects using a pyrolysis reactor. A result associated with the set of objects can be generated, where the result is based on or includes the predicted chemometric property.
    Type: Application
    Filed: November 21, 2023
    Publication date: May 23, 2024
    Applicant: X Development LLC
    Inventors: Aleksandra Spyra, Diosdado Banatao, Clare Lee, Allen Zhao, Gearoid Murphy, Daniel Rosenfeld, Alexander Holiday
  • Publication number: 20230201283
    Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus (RVV), compositions comprising the RVV, and use of the RVV or composition for inducing oncolysis in an individual having a tumor.
    Type: Application
    Filed: January 5, 2021
    Publication date: June 29, 2023
    Inventors: Joseph John Binder, Michael Dale Eisenbraun, Douglas Hanahan, David H. Kirn, Clare Lees, Prajit Limsirichai, Liliana Maruri Avidal
  • Patent number: 11529402
    Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus; and compositions comprising the replication-competent, recombinant oncolytic vaccinia virus. The present disclosure also provides use of the vaccinia virus or composition for inducing oncolysis in an individual having a tumor.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: December 20, 2022
    Assignee: Ignite Immunotherapy, Inc.
    Inventors: Douglas Hanahan, David H. Kirn, Liliana Maruri Avidal, Michael D. Eisenbraun, Joseph J. Binder, Clare Lees
  • Publication number: 20220033784
    Abstract: The present disclosure provides human IL-2 variants, recombinant oncolytic viruses comprising the IL-2 variant, compositions comprising the IL-2 variant or recombinant oncolytic virus, and use of the IL-2 variants, recombinant oncolytic virus, or compositions for treating cancer in an individual.
    Type: Application
    Filed: July 9, 2021
    Publication date: February 3, 2022
    Applicant: Pfizer Inc.
    Inventors: Joseph John Binder, Michael Dale Eisenbraun, Clare Lees, Jeremy Shawn Myers, James Travis Patterson
  • Publication number: 20200222520
    Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus; and compositions comprising the replication-competent, recombinant oncolytic vaccinia virus. The present disclosure also provides use of the vaccinia virus or composition for inducing oncolysis in an individual having a tumor.
    Type: Application
    Filed: January 9, 2020
    Publication date: July 16, 2020
    Applicant: Ignite Immunotherapy, Inc.
    Inventors: Douglas Hanahan, David H. Kirn, Liliana Maruri Avidal, Michael D. Eisenbraun, Joseph J. Binder, Clare Lees
  • Patent number: 9216229
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: December 22, 2015
    Assignee: Pfizer Vaccines LLC
    Inventors: Alan Daniel Brown, Brian Robert Champion, Clare Lees, David Paul Gervais, Lyn Howard Jones, Anne Maria Kristina Kjerrstrom, David Cameron Pryde, Lee Richard Roberts, David Michael Wyatt
  • Publication number: 20140004142
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide containing a phosphorylation site (with or without phosphorylation of the site) linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositions thereof and their use in medicine.
    Type: Application
    Filed: February 28, 2012
    Publication date: January 2, 2014
    Applicant: PFIZER INC.
    Inventors: Brian Robert Champion, James Downey Fraser, George Joseph Smith, Clare Lees